Clinical Trials · NCT01455857
A Study to Evaluate ITCA 650 for the Treatment of Type 2 Diabetes
- Phase
- Phase 3
- Recruitment status
- Completed
- Sponsor
- Intarcia Therapeutics
- Enrollment
- 460
- Start date
- Mar 2013
- Locations
- 121 sites, United States
- Primary endpoint
- Change in HbA1c